Company MultiCell Technologies, Inc. Other OTC
Equities
MCET
US62544S2005
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -.--% |
Sales per region
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -.--% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,448 | 0 | 0 | 90.01 % |
Stock B | 1 | 5,000,948,700 | 4,501,353,925 ( 90.01 %) | 0 |
Company contact information
MultiCell Technologies, Inc.
4144 North Central Expressway Suite 600
75204, Dallas
+
Sector
1st Jan change | Capi. | |
---|---|---|
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |